PMC:7076992 / 3261-3826
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T8 | 115-121 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T9 | 238-252 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T10 | 471-476 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid_AGAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p19822s20 | 299-306 | NegReg | denotes | reduced |
| p19822s21 | 307-319 | CPA | denotes | inflammation |
| p19822s23 | 324-334 | CPA | denotes | viral load |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T18 | 42-50 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T19 | 307-319 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T20 | 397-405 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 79-80 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T20 | 115-121 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T21 | 180-183 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T22 | 471-476 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T23 | 482-490 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
| T24 | 536-546 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T17 | 177-179 | Chemical | denotes | Co | http://purl.obolibrary.org/obo/CHEBI_27638 |
| T18 | 498-506 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 307-319 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
| T2 | 525-546 | http://purl.obolibrary.org/obo/GO_0006956 | denotes | complement activation |
| T3 | 551-563 | http://purl.obolibrary.org/obo/GO_0006909 | denotes | phagocytosis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 0-148 | Sentence | denotes | There are currently over 30,000 recovered COVID-19 patients, who could present a valuable resource of convalescent plasma for health care providers. |
| T27 | 149-339 | Sentence | denotes | China National Biotec Group Co has claimed that 10 seriously ill patients receiving this immunoglobulin therapy demonstrated improved oxygenation and reduced inflammation and viral load [7]. |
| T28 | 340-565 | Sentence | denotes | High-titer specific antibodies should be able to bind to SARS-CoV-2 and neutralize the viral particles, block access to uninfected cells, and activate potent effector mechanisms (e.g., complement activation and phagocytosis). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 81 | 51-59 | Species | denotes | patients | Tax:9606 |
| 82 | 214-222 | Species | denotes | patients | Tax:9606 |
| 83 | 397-407 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 84 | 42-50 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 85 | 307-319 | Disease | denotes | inflammation | MESH:D007249 |